HIV incidence is high among pregnant and postpartum women and increases the risk of mother-to-child transmission

Michael Carter
Published: 25 March 2014

HIV incidence is high among pregnant and postpartum women and is associated with an increased risk of mother-to-child transmission (MTCT) of HIV, results of a systematic review and meta-analysis published in PLOS Medicine show. The investigators stress the importance of offering repeat HIV tests to women in high-prevalence settings during pregnancy and breastfeeding.

Many women have an ongoing risk of acquiring HIV during pregnancy and breastfeeding. Therefore guidelines recommend that women who are identified as HIV negative during initial antenatal screening should have repeat HIV tests during pregnancy and postpartum. This rarely occurs, and to better inform prevention strategies, a team of US investigators performed a systematic review and meta-analysis of studies examining the incidence of HIV during pregnancy and postpartum and its association with vertical (mother to child) transmission of HIV.

Their review included studies published or presented to conferences between 1980 and the autumn of 2013. A total of 47 were included in their analysis.

Nineteen cohort studies – all involving people in sub-Saharan Africa – looked at incidence rates among pregnant and postpartum women. A total of 22,803 women were enrolled in the cohorts. The pooled results showed that HIV incidence was 3.8 per 100 person-years during pregnancy and 2.9 per 100 person-years postpartum.

Incidence of infection during pregnancy/postpartum was highest in southeast Africa (6.2 per 100 person-years), followed by south Africa (4.8 per 100 person-years), east Africa (2.7 per 100 person-years) and west Africa (0.7 per 100 person-years). Incidence was significantly higher in southeast Africa compared to west and east Africa.

“The pooled incidence rates we observed were comparable to, or higher than, those of non-pregnant ‘high risk’ individuals, including female sex workers…HIV-discordant couples…and men who have sex with men,” note the authors. “Both biological and behavioral changes have been hypothesized to explain the potentially higher risk of HIV acquisition observed during pregnancy and the postpartum period.”

Data on cumulative incidence rates during pregnancy/postpartum were provided in five studies, showing this was significantly higher in African compared to non-African settings (3.6 vs 0.3%; p < 0.001).

Rates of MTCT among women with incident infections during pregnancy/postpartum were reported in 13 studies. Vertical transmission rates ranged from 13% in the United States to 58% in Rwanda, with a pooled rate of 22.7%. Comparison between African and non-African settings showed a similar rate of vertical transmission (23.6 vs 22%, respectively). The pooled MTCT rate among women who acquired HIV during pregnancy was 17.8%, compared to 26.9% among women who acquired HIV postpartum, a non-significant difference.

Five studies compared the risk of MTCT among women with new infections during pregnancy/postpartum versus women with chronic HIV infection. Overall, infection with HIV during pregnancy/postpartum was associated with an almost threefold increase in the risk of MTCT (OR = 2.8; 95% CI, 0.9-4.7).

“HIV incidence among pregnant and postpartum populations was high in this meta-analysis and may substantially increase risk of MTCT,” conclude the investigators. “Our results have several implications for antenatal care/PMTCT programs.” First, all women in high-prevalence settings should be offered repeat HIV tests to detect incident infections during pregnancy/postpartum. Second, more sensitive testing assays should be used that detect both HIV antibodies and p24 antigen. Third, pregnant and postpartum women should receive counselling about the importance of ongoing condom use. The authors also believe that these women should be involved in the development of female-controlled methods of prevention, such as microbicides.


Drake AL et al. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLOS Medicine, 11(2): e1001608, 2014.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.